GOCO vs GRAN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GOCO exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a catastrophic collapse in top-line performance with YoY revenue growth plummeting -96.80% and an operating margin of -252.92%. While the stock trades at a deep discount to book value (P/B 0.45) and sales (P/S 0.08), these appear to be value traps given the trajectory of the business. Despite a bullish analyst target of $4.70, the deterministic data suggests a company in a death spiral with a -99.4% five-year price return.
Grande Group Limited presents a contradictory profile where a stable Piotroski F-Score (6/9) and strong liquidity (Current Ratio 4.69) mask a severe operational collapse. The company has suffered a catastrophic revenue decline of 83.20% YoY and is operating with a deeply negative operating margin of -408.73%. With a technical trend of 0/100 and a 72.4% decline over the past year, the stock is in a clear bearish regime despite its low debt levels.
Compare Another Pair
Related Comparisons
GOCO vs GRAN: Head-to-Head Comparison
This page compares GoHealth, Inc. (GOCO) and Grande Group Limited (GRAN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.